| 发明名称 | Treating neurodegenerative diseases with GGA or a derivative thereof | ||
| 摘要 | Provided herein are methods for improving negative effects of ALS, AD, or ischemia, the methods comprising administering to a subject in need thereof a therapeutically effective amount of GGA, preferably present in the trans form, or a derivative thereof. | ||
| 申请公布号 | US9119808(B1) | 申请公布日期 | 2015.09.01 |
| 申请号 | US201314045219 | 申请日期 | 2013.10.03 |
| 申请人 | Coyote Pharmaceuticals, Inc. | 发明人 | Serizawa Hiroaki |
| 分类号 | A61K31/12;A61K31/121 | 主分类号 | A61K31/12 |
| 代理机构 | Foley & Lardner LLP | 代理人 | Foley & Lardner LLP |
| 主权项 | 1. A method of treating amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), or ischemia, the method comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from: | ||
| 地址 | Menlo Park CA US | ||